First international chapter of Life Science Cares established in Switzerland – bringing hearts and minds together by empowering the life sciences industry to support local communities.
Today Life Science Cares, a collective effort of the life science industry to reduce the impact of poverty and inequality in their communities, launched in Switzerland, marking its first expansion as an independent association into geographies outside of the United States.
“We are excited to launch Life Science Cares Switzerland (LSCS) today, in time, to engage with the local community at the upcoming Swiss Biotech Day in Basel,” said Nadine Zahnd, Managing Director of LSCS. “At the heart of our life sciences community is the overwhelming sense to act and do good. We are building bridges between Swiss Life Science Organizations and local charitable organizations for individuals who may otherwise fail to access the opportunities afforded to so many of us.” 
In Switzerland in 2021, 1.24 million people, including many families, are considered at the brink of poverty. Those affected are at risk of losing their social contacts and often suffer from psychological and physical health problems. Children in such families face often insurmountable obstacle to reach their full potential. It is the mission of LSCS to break this cycle and offer a path to unlock opportunity.
“On behalf of Life Science Cares’ leadership across the US, we are thrilled to welcome our Swiss colleagues to this collective effort,” said Life Science Cares CEO Sarah MacDonald. “We are impressed by the work the team has done to galvanize the life sciences community and begin to build strong connections to community-based organizations to make meaningful change.”
LSCS will launch at Swiss Biotech Day and be showcased in the April 22nd Plenary Session and in a dedicated panel discussion featuring the Swiss Red Cross, Cooley LLP, Novartis, the Swiss Biotech Association (SBA) and Molecular Partners. Information will be available for everyone who wishes to contribute to the LSCS mission at the SBA Booth.
The Board of LSCS will be constituted by Isabel Dalli, Novartis; Sarah MacDonald, CEO LSC, Inc.; Dorothea Bergler, Swiss Red Cross; Patrick Amstutz, Swiss Biotech Association / Molecular Partners; Dieter Gericke, Homburger; Christoph Schmidt, up&up communication.
Founding Members include Ulf Grawunder, Founder and former CEO of NBE Therapeutics; Bill Burns, former CEO of Roche Pharmaceuticals; Dominik Hochli, former Head of Global Medical Affairs at Abbvie; Patrick Amstutz, CEO of Molecular Partners and Chairman of Swiss Biotech Association, as well as Molecular Partners, the Swiss Biotech Association, HBM Healthcare Investments and others.
LSC Switzerland’s founding team celebrates incorporation.
About Life Science Cares
Life Science Cares (LSC) activates the financial and human capital of the life sciences industry and partners with nonprofits to disrupt the cycle of poverty and inequality in our communities. Now operating in five US life science hubs (Boston, Philadelphia, San Diego, the San Francisco Bay Area and New York), LSC has invested $16 million and tens of thousands of volunteer hours in community organizations providing access to basic needs, access to education or access to opportunity. Life Science Cares Switzerland, the first international LSC effort, launched in April 2024. Learn more at https://lifesciencecares.org/.